bioRxivMicrobiology
Identification of a Small Molecule Inhibitor of the Aminoglycoside 6’-N-Acetyltransferase Type Ib [AAC(6’)-Ib] Using Mixture-Based Combinatorial Libraries
T. Tran, K. Chiem, S. Jani, B. Arivett, D. Lin, R. Lad, V. Jimenez, M. Farone, G. Debevec, R. Santos, M. Giulianotti, C. Pinilla, M. Tolmasky
Abstract
The aminoglycoside 6'-N-acetyltransferase type Ib [AAC(6)-Ib] is the most widely distributed enzyme among AAC(6)-I-producing Gram-negative pathogens and confers resistance to clinically relevant aminoglycosides including amikacin. This enzyme is therefore ideal to target with enzymatic inhibitors that could overcome resistance to aminoglycosides. The search for inhibitors was carried out using mixture-based combinatorial libraries, the scaffold ranking approach, and the positional scanning strategy. A library with high inhibitory activity had pyrrolidine pentamine scaffold and was selected for further analysis. This library contained 738,192 compounds with functionalities derived from 26 different amino acids (R1, R2 and R3) and 42 different carboxylic acids (R4) in four R group functionalities. The most active compounds all contained S-phenyl (R1 and R3) and S-hydromethyl (R2) functionalities at three locations and differed at the R4 position. The compound containing 3-phenylbutyl at R4 (compound 206) was a robust enzymatic inhibitor in vitro, in combination with amikacin potentiated the inhibition of growth of three resistant bacteria in culture, and improved survival when used as treatment of Galleria mellonella infected with aac(6)-Ib-harboring Klebsiella pneumoniae and Acinetobacter baumannii strains.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Structure-activity relationship of pyrrolidine pentamine derivatives as inhibitors of the aminoglycoside 6'-N-acetyltransferase type Ib
Jan Sklenicka, Tung Tran, … Marcelo E. Tolmasky·AntibioticsPeer-reviewed·Jul 19, 2024
- Dynamics and quantitative contribution of the aminoglycoside 6'-N-acetyltransferase type Ib to amikacin resistance
O. d'Udekem d'Acoz, F. Hue, … R. Reyes Lamothe·bioRxiv·Sep 5, 2023
- Restoration of Susceptibility to Amikacin by 8-Hydroxyquinoline Analogs Complexed to Zinc
J. Magallon, K. Chiem, … M. Tolmasky·bioRxiv·Apr 5, 2019
- Amikacin potentiator activity of zinc complexed to a pyrithione derivative with enhanced solubility
J. Magallon, P. Vu, … M. E. Tolmasky·bioRxiv·Oct 8, 2021
- Fatty acid biosynthesis inhibitors fabimycin and triclosan trigger distinct resistance mutations in FabI and potently kill Gram-negative pathogens
Brett N. Cain, James E. Kent, … Andrei L. Osterman·ACS Infectious DiseasesPeer-reviewed·Aug 24, 2026
- A Con Artist: Phenylphenoxybenzamide is not a Glycosyltransferase Inhibitor
Gjalt G. Wybenga, Wei-Shen Wu·bioRxiv·Apr 11, 2018